As a new marketing firm specializing in cell and gene therapy, we needed a site that defined our services, positioned our brand, and delivered a premium user experience. We solved this with a lean, conversion-focused design and vibrant seaside imagery that reinforces our name. Clear messaging, intuitive navigation, and subtle motion create a memorable, professional presence that stands out in biotech marketing.

AllCells is a trusted provider of primary cells for medical research and drug development, but their outdated brand failed to reflect their leadership in the space. We led a strategic refresh, clarifying their messaging, modernizing their visual identity, and highlighting the scientific beauty of their products. The result was a cohesive, elevated brand experience that boosted awareness, conversions, and contributed to the company’s acquisition by Discovery Life Sciences.

Medacta, a Swiss innovator in orthopaedic implants, needed to reshape perceptions and educate key influencers beyond price and scale. We developed a precise, professional brochure that highlights Medacta’s holistic value—training, implant accuracy, and post-surgical support. Designed to resonate with surgeons and hospital leaders navigating value-based care, the piece elevates credibility and positions Medacta as a trusted partner in surgical efficiency, outcomes, and patient safety.

To support Dexcom’s CGM products, we created tailored materials for pharmacists and consumers. Sell sheets used branded infographics and data-driven visuals to highlight the clinical and economic value of CGM. A flexible newsletter template balanced brand consistency with usability across print and digital formats, serving both internal teams and select customers. Together, these assets helped Dexcom educate, engage, and differentiate across key audiences.

To support both physicians and patients, the Prestalia website was designed with a dual-entry portal that tailors content to each audience. The minimalist logo, featuring three interconnected circles, symbolizes healthy blood flow and reinforces the brand’s clinical focus. The responsive site includes intuitive navigation, patient stories, and a dedicated healthcare professional section—creating a unified, accessible experience that builds trust and engagement.

To address low awareness and unfocused messaging, we created a bold, high-level brochure that repositions OrganaBio as a disruptive force in cell therapy development. Vibrant colors, dynamic layouts, and simplified messaging highlight their regionally placed CPC services and client-centric model. The piece pushes their brand toward greater consistency and impact, serving as both a marketing tool and a visual foundation for future channels like presentations and social media.

To help BioMauris gain credibility in the cannabis industry, we created a dynamic investor pitch deck showcasing their pharmaceutical roots and advanced tracking technology. The deck highlighted their platform’s ability to connect prescriptions, patient outcomes, and inventory movement—adapted for seed-to-sale regulation. Eye-catching visuals, clear messaging, and flexible design positioned BioMauris as a data-driven player ready to lead in a rapidly evolving market.

To build awareness for our cell and gene therapy marketing firm, we developed a range of digital assets—including social media graphics, email designs, and case studies. Unified by a distinct visual style, the materials were designed to attract attention, drive engagement, and establish our brand identity. This collage of deliverables helped position Orange County Bio as a standout creative partner in a highly specialized space.

For Abbott Diabetes Care, we developed targeted print ads, sell sheets, and emails to support institutional meters and test strips. The campaign elevated contamination risk as a critical decision factor, connecting it to patient and clinician safety. With strong visuals, evidence-based messaging, and a precise yet caring tone, the materials positioned Abbott as a leader in infection control—driving action among clinical decision-makers in a highly competitive market.